Entries by Hannah Thomson

Evaluation of ETS2101 in Combination with anti-mCTLA4 Monoclonal Antibody on CD4 and CD8 TILs in a Subcutaneous CT-26 Colorectal Cancer Model  

OracleBio presented a poster at the 2017 Annual Meeting of the American Association for Cancer Research (AACR), on Sunday 2nd April in Washington D.C. The poster, made in collaboration with E-Therapeutics, is entitled ‘Evaluation of ETS2101 in Combination with anti-mCTLA4 Monoclonal Antibody on CD4 and CD8 TILs in a Subcutaneous CT-26 Colorectal Cancer Model’ and is provided […]

Quantitative Image Analysis of Fibrotic Lesion Progression in the Mouse Bleomycin Model of Pulmonary Fibrosis

OracleBio data was presented on a poster at the Keystone Symposia Injury, Inflammation and Fibrosis Conference, taking place 26th – 30th March 2017. The poster, made in collaboration with Charles River and Grünenthal, is entitled ‘Quantitative Image Analysis of Fibrotic Lesion Progression in the Mouse Bleomycin Model of Pulmonary Fibrosis’ and is provided in full below. Click to […]

OracleBio adds Visiopharm Oncotopix software for Image Analysis

OracleBio, a global leader in high precision, quantitative digital image analysis services, is pleased to announce an expansion of its software capabilities to include Visiopharm Oncotopix®. Produced by Denmark-based Visiopharm, Oncotopix® software is an advanced platform for computer assisted quantification of immunohistochemistry (IHC) and In-Situ Hybridization (ISH) staining. Oncotopix offers a portfolio of software modules designed for […]

Next Gen Immuno-Oncology Congress, London

OracleBio will be attending the Next Gen Immuno-Oncology Congress, which takes place from the 13th to the 14th of March in London. OracleBio provides a range of digital pathology image analysis services that support pre-clinical and clinical Immuno-Oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to […]

Immune Checkpoint Inhibitors Conference, Boston

OracleBio will be attending the Immune Checkpoint Inhibitors Boston Conference, which runs from the 14th to the 16th of March 2017. OracleBio offers a range of digital pathology image analysis services to support pre-clinical and clinical immuno-oncology R&D and have generated data as part of immune checkpoint inhibitor studies. In one recently published study, we performed […]

Content and Spatial Distribution Analysis of PD-L1 Positive Tumor Cells and CD8 Positive T-Cells within Multiplex IHC Stained NSCLC Tumor Tissue

OracleBio data was presented on a poster at the International Molecular Medicine Tri-Conference, which took place in San Francisco on the 19th – 24th February 2017. The poster, made in collaboration with Asterand Bioscience, is entitled ‘Content and Spatial Distribution Analysis of PD-L1 Positive Tumor Cells and CD8 Positive T-Cells within Multiplex IHC Stained NSCLC Tumor Tissue’ and is […]

Keystone Symposia Injury, Inflammation and Fibrosis Conference

OracleBio data will be presented on a poster at the Keystone Symposia Injury, Inflammation and Fibrosis Conference, taking place 26th – 30th March 2017 in Snowbird, Utah. The poster, made in collaboration with Charles River and Grünenthal, is titled ‘Quantitative Image Analysis of Fibrotic Lesion Progression in the Mouse Bleomycin Model of Pulmonary Fibrosis’. It is Poster No. 3041 […]